Factors related to COVID-19 severity and mortality based on comparison between Henan and Zhejiang: an observational study

DOI: https://doi.org/10.21203/rs.3.rs-24420/v1

Abstract

Background: Coronavirus Disease 2019 (COVID-19) has spread across China and the world, since outbreak at the end of 2019. Although COVID-19 is generally considered as self-limiting, some of cases develop in to fatal respiratory restress, multiple organ failure and even sudden death. According to the data released by the provincial health commissions, there are obvious regional differences in COVID-19 mortality. To explore possible factors of COVID-19 related severity and mortality in laboratory-confirmed cases from Henan and Zhejiang.

Methods: We collected the public data released by the government. We analyzed and compared the possible factors, including initial symptoms, gender, age, place of residence, time interval from onset to diagnosis, epidemiological history and the grade of hospital for patient’s treatment in laboratory-confirmed cases. Student’s t-test, Chi-square (c2) test, Cochran-Mantel-Haenszel (CMH) test and Mann-Whitney U rank sum test were used complied with the applicable conditions. Statistical test was performed with a level of significance α=0.05.

Results: Death cases in Henan were mainly from male, elderly infected persons and those who had a history of contact with patients and underlying basic diseases. Henan had the higher proportion of cases with fever and the lower proportion of asymptomatic infection, and had higher proportions of imported male cases with a contact history, and elderly cases living in rural areas, relative to Zhejiang. The time interval of confirmed cases in rural areas of Henan was 0.8 day longer than that in Zhejiang. Hospitals grade for patients’ treatment in Henan was lower than Zhejiang.

Conclusions: Our findings suggest that initial symptoms, age, place of residence, gender, the time interval from onset to diagnosis and the grade of designated hospital for patient’s treatment are possible factors behind COVID-19 related severity or mortality. This study will provide useful information for public health authorities to develop disease prevention strategies.

Introduction

At the end of 2019, an emerging infectious disease named as Coronavirus Disease 2019 (COVID-19) occurred in several local hospitals of Wuhan, Hubei Province, China(1). Since then, continuous human to human transmissions were observed in Hubei and its outsides leading to more than 80,000 infected persons across mainland China(2). Based on clinical manifestations, blood tests and chest radiographs, this disease was initially considered as viral respiratory illness by clinicians(3). Subsequently, a novel human coronavirus named as severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) was identified from the bronchoalveolar lavage fluid (BALF) of COVID-19 patients(4, 5). COVID-19 is generally considered as a type of self-limiting infectious disease. Most of patients are mild, whereas some of patients develop into fatal respiratory distress posing a great threat to human life(4). To control the epidemic of COVID-19, a variety of interventions, such as containment strategy and emergency response were rapidly started by Chinese government. However, as lack of specific antiviral protection and vaccines available for COVID-19, more than 3,000 people died from this infectious disease in mainland China until March 09, 2020(2).

Epidemiological studies suggest that the most common factors related to COVID-19 severity or mortality are older age and concomitant disease(6). Of 44,672 laboratory confirmed cases, the total case-fatality rate is 2.3% (male: 2.8%; female: 1.7%), In contrast, the case-fatality rate of patients over 80-year-old is as high as 14.8%, and the case-fatality rate of patients with cardiovascular disease, diabetes, chronic respiratory disease, hypertension and cancer is 10.5%, 7.3%, 6.3%, 6.0% and 5.6%, respectively(6). Additionally, the case-fatality of critical cases is more than 50%, which is higher than SARS(7). According to the data released by the provincial Health Commissions, there are obvious regional differences in COVID-19 mortality(8). For example, Guangdong, Henan and Zhejiang had similar number of cases (1331, 1262, 1173) until 19 February, 2020, but the case-fatality rates were quite different (0.4%, 1.5%, 0.0%)(8). To figure out possible factors of COVID-19 related severity and mortality, clinical features, epidemiological characteristics and designated hospitals of Henan and Zhejiang were analyzed and compared in this study. This study will provide useful information for public health authorities to develop disease prevention strategies.

Materials And Methods

Data source

All data was collected from public data released by the government, including National Health Committee of the People's Republic of China (http://www.nhc.gov.cn/), Health Commission of Henan Province (http://www.hnwsjsw.gov.cn/Template/fangkong.shtml), Health Commission of Zhejiang Province (http://www.zjwjw.gov.cn/col/col1202101/index.html) and other official websites of urban areas.

By February 19, 2020, 1262 laboratory-confirmed cases, including 19 deaths (3 deaths with unknown information) were collected in Henan Province, while 1105 laboratory confirmed cases were collected from Zhejiang Province and no deaths was reported.

Data Extraction And Entry

Forms used for web data extraction were made by ourselves. Before conducting data extraction, all research participants need to undergo unified training. The main extracted information was gender, age, place of residence, time interval from onset to diagnosis, epidemiological contact history, etc. Data were entered twice into the software Microsoft Office Excel 2016 (Microsoft Corporation, Washington, USA) to correct for typing errors.

Statistical analysis

All statistical analyses were evaluated with SPSS 25.0 software (SPSS lnc. IBM, Chicago, IL, USA). Quantitative variables were expressed as mean ± standard deviations (SD). Qualitative variables were expressed as ratios or rates (%). Rank variables were expressed as mean rank. Comparisons between quantitative variables were tested by using Student’s t-test. The Chi-square (χ2) test was used to compare the statistical differences between qualitative variables. The Cochran-Mantel-Haenszel (CMH) test was applied to analyze stratified categorical data. Grading variables were analyzed by Mann-Whitney U rank sum test. Statistical test was performed with a level of significance α = 0.05.

Results

An overview of COVID-19 epidemic in Henan and Zhejiang

As shown in Fig. 1, Henan is located in the central China with a population of 106.06 million, and Zhejiang is located in the east China with a population of 53.37 million. Henan borders with Hubei, while Zhejiang is about 200 km from Hubei. On January 21, 2019, the two provinces started to announce information about epidemic situation, and the epidemic trend of these two provinces was very similar after analysis. The cumulative number of laboratory-confirmed cases in these two provinces began to increase rapidly after January 27. The existing number of laboratory-confirmed cases in both provinces had declined since February 7, whereas Zhejiang was less than that in Henan after February 10 (Additional file 1: Figure.1). For new laboratory-confirmed cases (Figure.2A), the number of cases in both provinces arose rapidly after January 24 and declined after February 3. The epidemic appeared two peaks on January 24 (132 confirmed cases) and February 3 (105 confirmed cases) in Zhejiang and one peak on February 3 (109 confirmed cases) in Henan. As shown in Figure.2B, the cumulative cure rate (%) in Zhejiang was higher than that in Henan. China CDC data(6) showed that COVID-19 related mortality mainly came from severe and critical cases and the case-fatality rate of critical cases was as high as 49%. As shown in Figure.2C, the severe rate of both provinces rapidly increased at the early phase and Henan reached a peak (33.33%) on January 23. Since January 27, the severe rates of both provinces began to decline and fluctuated around 10%. Notably, the number of critical cases in Henan was higher than that in Zhejiang since February 1, and the highest number of critical cases in Henan and Zhejiang was 38 and 31, respectively (Figure.2D). The number of critical cases in Henan and Zhejiang began to decrease after February 12 and 14, respectively. Taken together, higher severe rate at early epidemic phase, lower cure rate and higher number of critical cases may predict more deaths in Henan.

General Features Of Death Cases In Henan Province

Since February 5, deaths continued to be reported in Henan, but no deaths in Zhejiang until February 19. A total of 19 deaths was announced in Henan by February 19, and the general features of 16 death cases (3 deaths with unknown information) were placed in Table 1. The average age of these 16 deaths was (72 ± 12.42) years old with a gender ratio (male/female) of 5:3, and 93.75% (15), 56.25% (9), 31.25% (5), 6.25% (1) of them were ≥ 60-year-old, ≥ 70-year-old, ≥ 80-year-old, < 60-year-old, respectively. The common symptom of 9 cases with known information was fever (6, 66.7%). 6 cases (37.5%) lived in rural areas, and 9 cases (56.25%) lived in urban areas. The time interval from onset to hospitalization was (2.58 ± 2.71) days, and the time interval from onset to diagnosis was (6.77 ± 2.89) days, and time interval from onset to death was (12.08 ± 5.95) days (Figure.3). There were 3 imported cases (18.75%) coming from Wuhan, Hubei, and 10 (62.50%) non-imported cases including 8 confirmed cases (80.00%) having a history of close contact with patients. Additionally, underlying basic diseases, such as respiratory disorders, hypertension, cardiovascular diseases, diabetes and cancer were reported in 8 cases with detail information.

Table 1

General features of death cases in Henan Province

ID

Gender

(F/M)

Age

Place of residence

Symptoms

Days from onset to admission

Days from onset to diagnosis

Days from onset to death

Imported case?

Wuhan travel history?

Hubei travel history?

Case contact history?

Basic diseases

1

Male

70 ~ 80

Rural

Cough/asthma

7

10

10

Yes

Yes

Yes

UN

Chronic bronchitis

2

Male

80~

Rural

Fever/cough/sputum /asthma

1

4

5

Yes

Yes

Yes

UN

Chronic bronchitis/CVD

3

Male

60 ~ 70

Rural

UN

UN

7

8

No

No

No

Yes

Diabetes/hypertension/CVD

4

Female

80~

Urban

UN

1

4

8

No

No

No

Yes

UN

5

Female

70 ~ 80

Urban

UN

UN

UN

UN

No

No

No

Yes

UN

6

Male

70 ~ 80

Urban

UN

UN

UN

UN

No

No

No

Yes

UN

7

Female

80~

Urban

UN

6

8

19

No

No

No

Yes

Diabetes/CVD/hypothyroidism

8

Male

70 ~ 80

Urban

Diarrhea/nausea/

vomiting

1

10

19

UN

UN

UN

UN

Hypertension/diabetes

9

Male

60 ~ 70

Rural

Fever

8

9

11

No

No

No

Yes

Lung cancer

10

Male

60 ~ 70

UN

UN

UN

UN

UN

UN

UN

UN

UN

UN

11

Male

60 ~ 70

Rural

Fever

2

4

19

Yes

Yes

Yes

UN

UN

12

Male

Under 60

Urban

Fever

1

10

20

No

No

No

UN

UN

13

Male

60 ~ 70

Urban

Constipation

1

8

9

UN

UN

UN

UN

UN

14

Female

60 ~ 70

Urban

UN

1

8

21

No

No

No

UN

Hypertension/CVD

15

Female

80~

Rural

Fever/cough

1

5

8

No

No

No

Yes

UN

16

Female

80~

Urban

Fever

1

1

UN

No

No

No

Yes

Hypertension

Note: unknown (UN); cardiovascular diseases (CVD);

Presentation of initial symptoms of laboratory-confirmed cases in Henan and Zhejiang

Due to individual differences in different patients or factors such as viral virulence and quantity, the initial symptoms of patients after infection often differ. The different initial symptoms may indicate different disease progression and outcomes. Based on the above considerations, we briefly describe and compare the initial symptoms of patients in the two provinces. We finally collected 939 cases in Zhejiang province and 676 cases in Henan province with the data of initial symptoms. As is shown in Figure.4, there were many differences in the initial symptoms of patients between the two provinces. Markedly, the results showed that 87.4% of the patients in Henan had fever in their initial symptoms, compared with Zhejiang Province (75.1%), with significant significances (P < 0.001). However, 37.8% of patients in Zhejiang Province had more cough than that in Henan Province (17.2%), with significant significances (P < 0.001). Most other initial symptoms are statistically different (Table 2). It was worth noting that 2.1% of infected persons were asymptomatic in Henan, while 7.2% of patients were asymptomatic in Zhejiang (P < 0.001). However, potential information bias should be considered here. For instance, most of the data reported by Henan didn’t include CT imaging performance, and fever and asymptomatic were commonly information reported by both provinces. Herein, the above data indicate that Henan has a higher proportion of patients with fever and lower proportion of patients with asymptomatic.

Table 2

Presentation of initial symptoms of laboratory-confirmed cases in Henan and Zhejiang

Province and symptoms

Zhejiang (n = 939)

Henan (n = 676)

χ2

P

Fever

       

Yes

705(75.1%)

591(87.4%)

37.797

< 0.001

No

234(24.9%)

85(12.6%)

Cough

       

Yes

355(37.8%)

116(17.2%)

81.101

< 0.001

No

584(62.2%)

560(82.2%)

Expectoration

       

Yes

83(8.8%)

24(3.69%)

17.772

< 0.001

No

856(91.2%)

652(96.4%)

Rhinobyonh or rhinorrhea

       

Yes

41(4.4%)

17(2.5%)

3.892

0.049

No

898(95.6%)

659(97.5%)

Sore throat

       

Yes

87(9.3%)

26(3.8%)

17.737

< 0.001

No

852(90.7%)

650(96.2%)

Chest pain or shortness of breath

       

Yes

26(2.8%)

27(4.0%)

1.859

0.173

No

913(97.2%)

649(96.0%)

Muscle ache or fatigue

       

Yes

125(13.3%)

61(9.0%)

7.093

0.008

No

814(86.7%))

615(91.0%)

Headache or dizziness

       

Yes

95(10.1%)

22(3.3%)

27.547

< 0.001

No

844(89.9%))

654(96.7%)

Nausea and vomiting

       

Yes

19(2.0%)

12(1.8%)

0.129

0.720

No

920(98.0%))

664(98.2%)

Diarrhoea

       

Yes

20(2.1%)

4(0.6%)

6.325

0.012

No

919(97.9%))

672(99.4%)

Abnormal CT image

       

Yes

263(28.0%)

2(0.3%)

220.070

< 0.001

No

676(72.0%))

674(99.7%)

Asymptomatic

       

Yes

68(7.2%)

14(2.1%)

21.804

< 0.001

No

871(92.8%))

662(97.9%)

Overall Comparison Of Laboratory-confirmed Cases In Henan And Zhejiang

Of total confirmed cases, the proportion of male and female was 50.5%, 49.5% in Zhejiang, and 54.4%, 45.6% in Henan. The proportion of male in Henan was higher, but the difference had no statistically significance (P > 0.05). The mean age of the confirmed cases in Zhejiang was (47.25 ± 15.30), which was higher than that in Henan (44.31 ± 16.06) with significant difference (P < 0.001). Next, we performed a stratified analysis of age distribution. The proportion of 19 ~ 35-year-old confirmed cases (28.9%) in Henan was higher than that in Zhejiang (20.7%) (P < 0.001). The proportion of 36 ~ 59-year-old (56.2%) and ≥ 60-year-old confirmed cases (20.3%) in Zhejiang was higher than that in Henan (51.8%, 15.1%), with significant significances (P = 0.033, P = 0.001) (Additional file 1: Table 1). 79.6% of confirmed cases lived in urban areas of Zhejiang, which was higher than that in Henan (49.7%) with a significant difference (P < 0.001). Compared with Zhejiang (46.3%), the proportion of imported cases in Henan (54.4%) was higher, and the difference had a statistically significance (P < 0.001). 41.9% and 44.0% of the confirmed cases in Zhejiang had Hubei and Wuhan travel history, which was lower than that in Henan (57.4%, 54.6%). 85.5% of the confirmed cases in Zhejiang had a history of contact with case, which was lower than that in Henan (91.6%). The above differences were statistically significant (P < 0.001). The time interval from onset to diagnosis in Henan was (7.35 ± 4.20) days, which was 0.4 day longer than that in Zhejiang (6.95 ± 4.09) days, but the difference was not statistically significant (P > 0.05) (Table 3). These results suggest the laboratory-confirmed cases in Henan mainly come from young, rural and imported infected persons with a Hubei or Wuhan travel history, relative to Zhejiang.

Table 3

Comparison of laboratory-confirmed cases in Henan and Zhejiang

Province and variables

Zhejiang n (%)

Henan n (%)

χ2/t

P

Gender

       

Male

542(50.5%)

686(54.4%)

3.603

0.058

Female

532(49.5%)

575(45.6%)

Total

1074(100%)

1261(100%)

   

Age (year)

       

(0–18)

30(2.8%)

53(4.2%)

29.781

< 0.001

(19–35)

220(20.7%)

363(28.9%)

(36–59)

604(56.2%)

652(51.8%)

(≥ 60)

218(20.3%)

190(15.1%)

Total

1074(100%)

1258(100%)

   

Place of residence

       

Urban areas

848(79.6%)

622(49.7%)

222.483

< 0.001

Rural areas

217(20.4%)

630(50.3%)

Total

1065(100%)

1252(100%)

   

Imported case

       

Yes

483(46.3%)

673(54.4%)

14.839

< 0.001

No

559(53.6%)

563(45.6%)

Total

1042(100%)

1236(100%)

   

From Hubei Province

       

Yes

392(41.9%)

596(57.4%)

46.914

< 0.001

No

543(58.1%)

443(42.6%)

Total

935(100%)

1039(100%)

   

From Wuhan city

       

Yes

404(44.0%)

567(54.6%)

21.753

< 0.001

No

514(56.0%)

472(45.4%)

Total

918(100%)

1039(100%)

   

Contact cases

       

Yes

511(85.5%)

514(91.6%)

10.779

0.001

No

87(14.5%))

47(8.4%)

Total

598(100%)

561(100%)

   

Age (year)

47.25 ± 15.30

44.31 ± 16.06

4.505

< 0.001

Time interval (day)

6.95 ± 4.09

7.35 ± 4.20

1.871

0.061

Comparison of laboratory confirmed cases in Henan and Zhejiang after adjusting for gender

Latest studies suggest that the male confirmed cases may have a higher case-fatality rate(6, 9). Nevertheless, the gender is a common confounding factor for other research factors. Than the stratified χ2 test was performed. 60.3% of male were imported cases in Henan, which were higher than that in Zhejiang (49.0%) with a significant difference (P < 0.001). The proportion of male confirmed cases with a case contact history in Henan (92.5%) was higher than that in Zhejiang (83.1%), with a statistically significant difference (P = 0.001). The differences of age in male/female confirmed cases between Henan and Zhejiang had statistically significance (P < 0.05). Compared to Zhejiang, the proportion of male/female confirmed cases living in rural areas of Henan was higher with statistically significant differences (P < 0.001). The proportion of male confirmed cases with a Hubei or Wuhan travel history was higher than that in Zhejiang, and all differences had statistically significances (P < 0.001). The time interval from onset to diagnosis of confirmed cases in Henan was higher than that in Zhejiang whatever male or female, but had no statistically significance (P > 0.05) (Table 4). Above results indicate that Henan has a higher proportion of male cases coming from rural areas, or imported cases with epidemiological history, relative to Zhejiang.

Table 4

Comparison of laboratory-confirmed cases in Henan and Zhejiang after adjusting for gender

Gender

Province

Variables

Total (n)

χ2

P

   

Imported case n (%)

     
   

No

Yes

     

Female

Zhejiang

293(56.8%)

223(43.2%)

516

2.022

0.155

Henan

297(52.5%)

269(47.5%)

566

Male

Zhejiang

266(51%)

256(49.0%)

522

15.044

< 0.001

Henan

266(39.7%)

404(60.3%)

670

   

Age n (%)

     
   

(0–18)

(19–35)

(36–59)

(≥ 60)

     

Female

Zhejiang

12(2.3%)

104(19.5%)

297(55.8%)

119(22.4%)

532

13.856

0.003

Henan

21(3.7%)

148(25.8%)

317(55.2%)

88(15.3%)

574

Male

Zhejiang

18(3.3%)

118(21.8%)

307(56.6%)

99(18.3%)

542

17.225

0.001

Henan

32(4.7%)

215(31.4%)

335(49.0%)

102(14.9%)

684

   

Place of residence n (%)

     
   

Urban areas

Rural areas

Female

Zhejiang

430(81.9%)

95(18.1%)

525

103.612

< 0.001

Henan

301(52.9%)

268(47.1%)

569

Male

Zhejiang

404(77.1%)

120(22.9%)

524

111.466

< 0.001

Henan

321(47.1%)

361(52.9%)

682

   

Hubei travel history n (%)

     
   

No

Yes

Female

Zhejiang

271(60.5%)

177(39.5%)

448

13.058

< 0.001

Henan

230(48.6%)

243(51.4%)

473

Male

Zhejiang

272(56.3%)

211(43.7%)

483

36.591

< 0.001

Henan

213(37.6%)

353(62.4%)

566

   

Wuhan travel history n (%)

     
   

No

Yes

Female

Zhejiang

257(58.8%)

180(41.2%)

437

5.364

0.021

Henan

242(51.2%)

231(48.8%)

473

Male

Zhejiang

257(53.9%)

220(46.1%)

477

18.237

< 0.001

Henan

230(40.6%)

336(59.4%)

566

   

Cases contact history n (%)

     
 

No

Yes

Female

Zhejiang

37(12.2%)

266(87.8%)

303

1.429

0.232

Henan

27(9.2%)

267(90.8%)

294

Male

Zhejiang

50(16.9%)

245(83.1%)

297

11.499

0.001

Henan

20(7.5%)

247(92.5%)

267

   

Time interval (day)

 

t

P

Female

Henan

7.20 ± 4.43

 

-1.285

0.199

Zhejiang

6.80 ± 3.95

 

Male

Henan

7.48 ± 4.01

 

-1.247

0.213

Zhejiang

7.11 ± 4.23

 

Comparison of laboratory-confirmed cases in Henan and Zhejiang after adjusting age

Age is an important factor for COVID-19 related severity or deaths, and most of deaths are elderly based on data from Chinese center for disease control and prevention (CDC)(6). Our results showed that the proportions of cases living in rural areas at different ages of Henan were higher than that in Zhejiang, with statistically significant differences (P < 0.05). Notably, the proportion of elderly cases living in rural areas in Henan is about 3 times of Zhejiang. 68.3% of 19 ~ 35-year-old cases in Henan were imported, which was higher than that in Zhejiang and the difference was statistically significant (P < 0.001). The proportion of young cases (19 ~ 35-year-old) who had a Hubei (69.8%) or Wuhan travel history (68.2%) in Henan was higher than that in Zhejiang (46.3%, 45.7%) with statistically significant differences (P < 0.001). 55.9% of cases at the age of 36 ~ 59 had a Hubei travel history in Henan, which was higher than that in Zhejiang (43.8%) with statistically significant difference (P < 0.001). The proportion of cases at 19 ~ 35 (95.4%) or 36 ~ 59-year-old (91.5%) who had a case contact history in Henan was higher than that in Zhejiang (84.5%, 82.4%) with statistically significant difference (P < 0.05). The time interval (from onset to diagnosis) of cases at 36 ~ 59-year-old (7.86 ± 4.45) days in Henan was longer than that in Zhejiang (7.16 ± 4.12) days, with statistically significant difference (P < 0.05) (Table 5). These results indicate that more older cases lived in rural areas of Henan predicting a low medical level, may be related to high case-fatality rate. Additionally, more young cases linked to an exposure of Hubei or Wuhan in Henan may be migrant workers, resulting in more imported cases at the same age level. The higher proportions of 36 ~ 59-year-old cases with a case contact history or longer interval from onset to diagnosis may be related to high severe rate or deaths in Henan.

Table 5

Comparison of laboratory-confirmed cases in Henan and Zhejiang after adjusting for age

Age

Province

Variables

Total (n)

χ2

P

   

Gender n (%)

     
   

Female

Male

     

(0–18)

Zhejiang

12(40.0%)

18(60.0%)

30

0.001

0.937

Henan

21(39.6%)

32(60.4%)

53

(19–35)

Zhejiang

104(46.8%)

118(53.2%)

222

2.074

0.150

Henan

148(40.8%)

215(59.2%)

363

(36–59)

Zhejiang

297(49.2%)

307(50.8%)

604

0.038

0.845

Henan

317(48.6%)

335(51.4%)

652

(≥ 60)

Zhejiang

119(54.6%)

99(45.4%)

218

2.779

0.096

Henan

88(46.3%)

102(53.7%)

190

   

Place of residence n (%)

     
   

Urban areas

Rural areas

(0–18)

Zhejiang

24(85.7%)

4(14.3%)

28

9.905

0.002

Henan

26(50.0%)

26(50.0%)

52

(19–35)

Zhejiang

169(79.0%)

45(21.0%)

214

65.899

< 0.001

Henan

160(44.3%)

201(55.7%)

361

(36–59)

Zhejiang

461(78.0%)

130(22.0%)

591

95.993

< 0.001

Henan

331(51.2%)

315(48.8%)

646

(≥ 60)

Zhejiang

180(83.3%)

36(16.7%)

216

38.552

< 0.001

Henan

104(55.0%)

85(45.0%)

189

   

Imported case n (%)

     
   

No

Yes

(0–18)

Zhejiang

17(56.7%)

13(43.3%)

30

0.008

0.928

Henan

30(57.7%)

22(42.3%)

52

(19–35)

Zhejiang

99(46.3%)

115(53.7%)

214

12.233

< 0.001

Henan

113(31.7%)

244(68.3%)

357

(36–59)

Zhejiang

288(49.7%)

292(50.3%)

580

2.927

0.087

Henan

286(44.8%)

353(55.2%)

639

(≥ 60)

Zhejiang

155(72.4%)

59(27.6%)

214

0.000

1.000

Henan

134(72.4%)

51(27.6%)

185

   

From Hubei province n (%)

     
   

No

Yes

(0–18)

Zhejiang

15(57.7%)

11(42.3%)

26

0.116

0.734

Henan

23(53.5%)

20(46.5%)

43

(19–35)

Zhejiang

109(53.7%)

94(46.3%)

203

28.686

< 0.001

Henan

96(30.2%)

222(69.8%)

318

(36–59)

Zhejiang

296(56.2%)

231(43.8%)

527

15.573

< 0.001

Henan

239(44.1%)

303(55.9%)

542

(≥ 60)

Zhejiang

123(70.3%)

52(29.7%)

175

1.401

0.237

Henan

85(63.9%)

48(36.1%)

133

   

From Wuhan city n (%)

     
   

No

Yes

(0–18)

Zhejiang

16(61.5%)

10(38.5%)

26

0.011

0.917

Henan

27(62.8%)

16(37.2%)

43

(19–35)

Zhejiang

107(54.3%)

90(45.7%)

197

25.700

< 0.001

Henan

101(31.8%)

217(68.2%)

217

(36–59)

Zhejiang

268(51.7%)

250(48.3%)

518

2.517

0.113

Henan

254(46.9%)

288(53.1%)

542

(≥ 60)

Zhejiang

123(71.1%)

50(28.9%)

173

0.418

0.518

Henan

90(67.7%)

43(32.3%)

133

   

Contact the case n (%)

     
   

No

Yes

(0–18)

Zhejiang

2(10.0%)

18(90.0%)

20

0.229

0.632*

Henan

1(2.9%)

33(97.1%)

34

(19–35)

Zhejiang

16(15.5%)

87(84.5%)

103

8.012

0.005

Henan

6(4.6%)

124(95.4%)

130

(36–59)

Zhejiang

56(17.6%)

263(82.4%)

319

10.822

0.001

Henan

24(8.5%)

260(91.5%)

284

(≥ 60)

Zhejiang

13(8.3%)

143(91.7%)

156

2.394

0.122

Henan

16(14.3%)

96(85.7%)

112

   

Time interval (day)

 

t

P

(0–18)

Zhejiang

4.70 ± 2.64

 

-0.320

0.751

Henan

5.00 ± 3.55

 

(19–35)

Zhejiang

6.73 ± 3.69

 

0.166

0.868

Henan

6.67 ± 3.43

 

(36–59)

Zhejiang

7.16 ± 4.12

 

-2.340

0.020

Henan

7.86 ± 4.45

 

(≥ 60)

Zhejiang

6.88 ± 4.45

 

-0.942

0.347

Henan

7.39 ± 3.35

 
Note: * indicates the P-value after correction.

Comparison of laboratory-confirmed cases in Henan and Zhejiang after adjusting for imported cases

Imported cases who have been infected at incubation, subclinical, or onset stage may lead to more severe cases or deaths, especially for the cases from Wuhan or Hubei. Our results showed 60.0% of imported cases in Henan are male, which was higher than that in Zhejiang (53.4%), with statistically significant difference (P < 0.05). Among non-imported cases, there was no difference in gender distribution between the two provinces (P > 0.05). There were also differences in age distribution in imported cases between Henan and Zhejiang (P < 0.001), and more imported cases with 19 ~ 35-year-old in Henan (P < 0.001) (Additional file 1: Table 1). Among imported cases, the proportion of cases having a Hubei travel history in Henan (90.1%) was higher than that in Zhejiang (81.2%) with a statistically significant difference (P < 0.001). Among non-imported cases, there was no statistically significant difference in visiting Hubei (P > 0.05). Among imported cases or non-imported cases, higher proportions of cases in Henan came from rural areas, relative to Zhejiang with statistically significant differences (P < 0.001). There was no significant difference between the two provinces about the imported and non-imported cases having a Wuhan travel history (P > 0.05). Among imported cases, 96.9% of cases having a case contact history in Henan, which were higher than that in Zhejiang (23.2%) with statistically significant difference (P < 0.001). Among non-imported cases, 100.0% of cases having a history of contact with cases in Zhejiang, which was higher than that in Henan (89.9%), and the difference was statistically significant (P < 0.001) (Table 6). Together, our results indicate that higher proportions of imported cases are male or have a Hubei travel history, or live in rural areas. As mentioned above, imported cases from Hubei lived in rural areas may be migrant workers.

Table 6

Comparison of laboratory-confirmed cases in Henan and Zhejiang after adjusting for imported case

Imported case

Province

Variables

Total (n)

χ2

P

   

Gender n (%)

     
   

Female

Male

     

No

Zhejiang

293(52.4%)

266(47.6%)

559

0.013

0.910

Henan

297(52.8%)

266(47.2%)

563

Yes

Zhejiang

223(46.6%)

256(53.4%)

479

4.959

0.026

Henan

269(40.0%)

404(60.0%)

673

   

Age n (%)

     
   

(0–18)

(19–35)

(36–59)

(≥ 60)

No

Zhejiang

17(3%)

99(17.7%)

288(51.5%)

155(27.7%)

559

6.039

0.110

Henan

30(5.3%)

113(20.1%)

286(50.8%)

134(23.8%)

563

Yes

Zhejiang

13(2.7%)

115(24%)

292(61%)

59(12.3%)

479

23.930

< 0.001

Henan

22(3.3%)

244(36.4%)

353(52.7%)

51(7.6%)

670

   

Place of residence n (%)

     
   

Urban areas

Rural areas

No

Zhejiang

430(77.3%)

126(22.7%)

556

50.988

< 0.001

Henan

322(57.3%)

240(42.7%)

562

Yes

Zhejiang

375(81.3%)

86(18.7%)

461

157.418

< 0.001

Henan

292(44.0%)

372(56.0%)

664

   

From Hubei province n (%)

     
   

No

Yes

 

No

Zhejiang

452(100.0%)

0(0.0%)

452

1.747

0.186*

Henan

373(99.2%)

3(0.8%)

376

Yes

Zhejiang

91(18.8%)

392(81.2%)

483

18.865

< 0.001

Henan

65(9.9%)

592(90.1%)

657

   

From Wuhan city n (%)

     
   

No

Yes

 

No

Zhejiang

447(99.3%)

3(0.7%)

450

0.000

1.000*

Henan

373(99.2%)

3(0.8%)

376

Yes

Zhejiang

67(14.3%)

401(85.7%)

468

0.000

0.997

Henan

94(14.3%)

563(85.7%)

657

   

Contact the case n (%)

     
   

No

Yes

No

Zhejiang

0(0.0%)

477(100.0%)

477

50.799

< 0.001

Henan

43(10.1%)

381(89.9%)

424

Yes

Zhejiang

86(76.8%)

26(23.2%)

112

139.936

< 0.001

Henan

4(3.1%)

126(96.9%)

130

   

Time interval (day)

 

t

P

No

Zhejiang

6.87 ± 4.34

 

-1.620

0.106

Henan

7.36 ± 4.38

 

Yes

Zhejiang

7.01 ± 3.67

 

-0.829

0.408

Henan

7.25 ± 3.97

 
Note: * indicates the P-value after correction.

Comparison of laboratory-confirmed cases in Henan and Zhejiang after adjusting place of residence

There is a big urban-rural gap in health resource allocation of public medical institutions in China(10), implying cases from rural areas may have a higher risk of developing severity or death. Our results showed that there was no statistical difference in gender after the stratification (P > 0.05). There were statistical differences in different age groups whatever rural or urban areas (P < 0.05). 21.6% of cases living in urban areas were ≥ 60-year-old in Zhejiang, which was higher than that in Henan (16.7%) with statistically significant difference (P < 0.05) (Additional file 1: Table 1). Consistent to early analysis, more cases at the age of 36 ~ 59-year-old or ≥ 60-year-old lived in rural areas in Henan, relative to Zhejiang, and the differences were statistically significant (P < 0.001). 60.8% of rural cases were imported cases in Henan, which were higher than that in Zhejiang (40.6%) with statistically significant difference (P < 0.001). Those who lived in rural areas of Henan with Hubei (66.7%) or Wuhan travel history (65.2%) were more than that in Zhejiang (35.0%, 38.7%), and the differences were statistically significant (P < 0.001). There were 91.9% of cases in urban areas having a contact history, which were higher than that in Zhejiang 85.5% with statistically significant differences (P < 0.05). The difference of time interval from onset to diagnosis between two provinces had no statistically significance (P > 0.05), but the time interval in rural areas of Henan was 0.8 day longer than Zhejiang (Table 7). Together, our data indicate that a higher proportion of elderly cases lived in rural areas of Henan, and more young cases with epidemiological history in Henan come from rural areas, relative to Zhejiang.

Table 7

Comparison of laboratory-confirmed cases in Henan and Zhejiang after adjusting place of residence

Address

Province

Variables

Total(n)

χ2

P

   

Gender n (%)

     
   

Female

Male

     

Urban areas

Zhejiang

430(51.6%)

404(48.4%)

834

1.429

0.232

Henan

301(48.4%)

321(51.6%)

622

Rural areas

Zhejiang

95(44.2%)

120(55.8%)

215

0.163

0.686

Henan

268(42.6%)

361(57.4%)

629

   

Age n (%)

     
   

(0–18)

(19–35)

(36–59)

(≥ 60)

     

Urban areas

Zhejiang

24(2.9%)

169(20.3%)

461(55.3%)

180(21.6%)

834

11.058

0.011

Henan

26(4.2%)

160(25.8%)

331(53.3%)

104(16.7%)

621

Rural areas

Zhejiang

4(1.9%)

45(20.9%)

130(60.5%)

36(16.7%)

215

13.433

0.004

Henan

26(4.1%)

201(32.1%)

315(50.2%)

85(13.6%)

627

   

Imported case n (%)

     
 

No

Yes

 

Urban areas

Zhejiang

430(53.4%)

375(46.6%)

805

0.132

0.716

Henan

322(52.4%)

292(47.6%)

614

Rural areas

Zhejiang

126(59.4%)

86(40.6%)

212

26.071

< 0.001

Henan

240(39.2%)

372(60.8%)

612

   

From Hubei province n (%)

     
 

No

Yes

 

Urban areas

Zhejiang

403(56.8%)

307(43.2%)

710

1.949

0.163

Henan

270(52.7%)

242(47.3%)

512

Rural areas

Zhejiang

130(65.0%)

70(35.0%)

200

59.560

< 0.001

Henan

172(33.3%)

345(66.7%)

517

   

From Wuhan city n (%)

     
 

No

Yes

 

Urban areas

Zhejiang

382(54.7%)

316(45.3%)

698

0.532

0.466

Henan

291(56.8%)

221(43.2%)

512

Rural areas

Zhejiang

122(61.3%)

77(38.7%)

199

41.345

< 0.001

Henan

180(34.8%)

337(65.2%)

517

   

Contact the case n (%)

     
 

No

Yes

 

Urban areas

Zhejiang

67(14.5%)

395(85.5%)

462

7.418

0.006

Henan

26(8.1%)

295(91.9%)

321

Rural areas

Zhejiang

15(12.2%)

108(87.8%)

123

1.000

0.317

Henan

21(8.9%)

216(91.1%)

237

   

Time interval (day)

 

t

P

Urban areas

Zhejiang

6.84 ± 4.00

 

0.1313

0.896

Henan

6.81 ± 3.97

 

Rural areas

Zhejiang

7.17 ± 4.02

 

-1.858

0.064

Henan

7.94 ± 4.36

 

Comparison of designated hospitals for COVID-19 treatment in Henan and Zhejiang

Generally, a higher-grade hospital will be beneficial for COVID-19 treatment. 147 and 100 designated treatment hospitals were announced by Henan and Zhejiang Heath Commissions, respectively (Figure.5A). Most of designated treatment hospitals in Henan were grade 2A (103), while designated treatment hospitals in Zhejiang were mainly from 3A (25), 3B (32) and 2A (37). In order to further explore whether there is really a difference in the level of treatment for those confirmed cases, we analyzed the medical level of the specific hospitals where the patients were treated. Together, we found that the patients in Zhejiang were indeed treated in higher-grade hospitals, and this difference was statistically significant (P < 0.001) (Figure.5B and Figure.5C).

Discussion

Currently, COVID-19 still remains a big challenge for China and global public health. Even though most of cases are asymptomatic or mild, a large number of severe cases have cost a lot of medical resources and pose a tremendous pressure on clinical treatment. Nowadays, few of cases continue to die every day which cause serious panic to society. Outside Hubei, the case-fatality rate of most provinces such as Zhejiang keeps an extremely low level, while some of provinces such as Henan and Heilongjiang far exceed national average level. Recent studies have indicated that gender (male), age (elder), and physical health (underlying basic disorders) are closely related to the adverse outcomes of the disease(4, 6). To deep understand factors behind COVID-19 related severity or mortality, we compared variables of initial symptoms, gender, age, place of residence, epidemiological history, time interval from onset to diagnosis and designated hospitals for COVID-19 treatment in Henan and Zhejiang.

First, we found that higher severe rate at early epidemic phase, lower cure rate and higher number of critical cases were found in Henan, relative to Zhejiang. It has been reported that most of deaths come from severe and critical cases(7), and lower cure rate may associate with medical level of Henan. Features of COVID-19 related deaths suggest that most of deaths come from elderly and male cases and those who have underlying basic diseases or a history of contact with cases, or live in rural areas. Previous study also indicated that elderly patients and those who have potential chronic diseases such as respiratory diseases, cardiovascular diseases, diabetes, hypertension and cancer(7, 11). Management of elderly patients, especially those with chronic diseases should be concerned in clinical practice(12). SARS-CoV-2, the pathogen of COVID-19, hijacks human angiotensin converting enzyme 2 (ACE2) receptor for cell entry, the expression of ACE2 involves with the severity of COVID-19(13, 14). Male persons with smoking showed higher ACE2 expression in lungs(9), which may explain the higher proportion of deaths in male population. Fever is an important predictor for the severity of infectious diseases(15, 16). Compare to Zhejiang, Henan has a higher proportion of cases with fever, which may support the higher severe rate of Henan in the early epidemic phase. Several studies have reported that asymptomatic patients can shed virus, but whether asymptomatic infection is contagious remains controversial(6, 17, 18). It is now generally accepted that asymptomatic infection is weak, indicating Zhejiang with a higher proportion of asymptomatic infection, may have more mild patients compared to Henan.

Next, we conducted stratified analysis of the data from these two provinces. Our findings suggest that most of imported cases in rural areas of Henan come from male young persons who have a Hubei or Wuhan travel history, or directly contact with cases. Henan is the largest labor export province in China, and the labor output is nearly 13 million in 2018(19). Therefore, we speculate this group of infected persons are migrant workers and return to Henan before the Spring Festival. The medical level and health literacy in rural areas are always lower than urban areas(20, 21). These group of infected persons predict to cause their family members infection, which is difficult to control. Therefore, Chinese governments at all levels adopted containment strategies at early phase of epidemic, and had been demonstrated to be effective.

Overall, the average age of cases in Zhejiang was higher than that in Henan, and most cases are middle-aged and elderly infected persons, because aging population in Zhejiang is more serious than in Henan(22, 23). However, the case-fatality rate was 0.0% until February 19, which was contrary to our original inference. Our further analysis indicates that most of elderly cases in Zhejiang live in urban areas, while the higher proportion of elderly cases in Henan live in rural areas with a longer time interval, and the time interval in rural areas of Henan is also longer relative to Zhejiang. The level of urbanization in Zhejiang is 68.9%, while Henan is only 51.71%(24, 25). There is a big urban-rural gap in health resource allocation of public medical institutions in China(10), Zhejiang has higher-grade of hospitals for COVID-19 treatment, which may explain a higher cure rate and lower severe rate compared to Henan. In the previous battles against SARS and H7N9(26, 27), advanced treatment strategy of severe respiratory diseases was also well established in Zhejiang, and a lower number of critical cases was observed in Zhejiang. The longer interval from onset to diagnosis can also affect the development of disease in elderly infected persons in Henan. As for above reasons, we think elderly cases living in rural areas may be responsible for the higher severe rate and number of critical cases, which further cause more deaths in Henan. At last, as lack of detail information of the reported cases from Henan and Zhejiang, there are certain limitations to our study.

Conclusion

In summary, our study found that higher proportions of patients with fever, imported male cases with a contact history, and elderly cases with a longer time interval from onset to diagnosis who live in rural areas, and the lower proportion of asymptomatic infection and the lower-grade of hospitals for COVID-19 treatment might be related to COVID-19 severity and mortality in Henan. Thus, our findings suggest that initial symptoms, age, place of residence, gender, the time interval from onset to diagnosis and the grade of designated hospital for patient’s treatment may be potential factors behind COVID-19 related severity or mortality.

Declarations

Ethics approval and Consent to participate

The data used in this study was completely from public data released by the government, so the ethics approval and consent to participate were not applicable.

Consent for publication

Not applicable.

Availability of data and materials

All data generated and analyzed during this study are included in this published article and its supplementary information files.The details are available from the following official websites: National Health Committee of the People's Republic of China (http://www.nhc.gov.cn/), Health Commission of Henan Province (http://www.hnwsjsw.gov.cn/Template/fangkong.shtml), Health Commission of Zhejiang Province (http://www.zjwjw.gov.cn/col/col1202101/index.html) and other official websites of urban areas.

Competing interests

The authors declare no conflict of interests.

Funding

This work was funded by the National Science and Technology Specific Projects (NO.2018ZX10301407); National Natural Science Foundation of China (NO.81172740 and NO.81573205); Project founded by China Postdoctoral Science Foundation (NO.2019M662543).

Authors' contributions

Wangquan Ji: Research concept and design, Supervision, Data analysis and interpretation, Data acquisition and verification, Writing original draft. Ruonan Liang: Data acquisition and verification, Data analysis. Peiyu Zhu: Data acquisition and verification, Data analysis. Haiyan Yang: Review and modify. Shuaiyin Chen: Review and modify. Weiguo Zhang: Review and modify. Guangcai Duan and Yuefei Jin: Conceptualization, Funding acquisition, Writing, Review & editing, Final approval of the version to be submitted.

Acknowledgements

Not applicable.

References

  1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine. 2020.
  2. National Health Commission of People's Republic of China. An Update of Novel Coronavirus Pneumonia Outbreak as of 24:00 on March 09.
  3. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. New England Journal of Medicine. 2020.
  4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020 Feb 15;395(10223):497-506. PubMed PMID: 31986264. Epub 2020/01/28. eng.
  5. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. <em>Severe acute respiratory syndrome-related coronavirus</em>: The species and its viruses – a statement of the Coronavirus Study Group. bioRxiv. 2020:2020.02.07.937862.
  6. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020 Feb 17;41(2):145-51. PubMed PMID: 32064853. Epub 2020/02/18. chi.
  7. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory medicine. 2020 Feb 24. PubMed PMID: 32105632. Epub 2020/02/28. eng.
  8. National Health Commission of People's Republic of China. An Update of Novel Coronavirus Pneumonia Outbreak as of 24:00 on February 19.
  9. Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv. 2020:2020.02.05.20020107.
  10. Li H, Chang GH. Disparity in Health Resource Allocation Between Rural and Urban Areas in China: Is It Getting Worse? Chinese Economy.41(6):45-55.
  11. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology. 2020 Feb 14. PubMed PMID: 32066541. Epub 2020/02/19. eng.
  12. Xu X-W, Wu X-X, Jiang X-G, Xu K-J, Ying L-J, Ma C-L, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020.
  13. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Feb 3. PubMed PMID: 32015507. Epub 2020/02/06. eng.
  14. Xin Zou KC, Jiawei Zou, Peiyi Han, Jie Hao, Zeguang Han. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front Med.0-.
  15. Qin L, Dang D, Wang X, Zhang R, Feng H, Ren J, et al. Identification of immune and metabolic predictors of severe hand-foot-mouth disease. PloS one. 2019;14(5):e0216993. PubMed PMID: 31120941. Pubmed Central PMCID: PMC6532886. Epub 2019/05/24. eng.
  16. Ashman RB, Müllbacher A. Infectious disease, fever, and the immune response. Immunology Today. 1984;5(9):268-71.
  17. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New England Journal of Medicine. 2020.
  18. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. Jama. 2020 Feb 21. PubMed PMID: 32083643. Pubmed Central PMCID: PMC7042844. Epub 2020/02/23. eng.
  19. Qiqi A. The Problem of Export of Labor Services in Henan Province and Its Countermeasures. jiangsu commercial forum. 2018.
  20. Karlsson EL. Care groups and primary health care in rural areas. Israel Journal of Medical Sciences. 1983;19(8):731-3.
  21. Pop OM, Brinzaniuc A, Sirlincan EO, Baba CO, Chereches RM. Assessing health literacy in rural settings: a pilot study in rural areas of Cluj County, Romania. Glob Health Promot.20(4):35-43.
  22. Henan Provincial People's Government. Henan Province actively responds to the population aging "Respect for the Elderly" Press Conference.
  23. Zhejiang Provincial People's Government. Reply of Zhejiang Provincial Market Supervision Bureau on Proposal No. 17 of the Second Session of the 13th National People's Congress.
  24. Henan Provincial People's Government. Population Profile of Henan Province.
  25. Zhejiang Provincial People's Government. Bulletin of main data of 1% population sampling survey in Zhejiang Province in 2018.
  26. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. The New England journal of medicine. 2013 Jun 13;368(24):2277-85. PubMed PMID: 23697469. Epub 2013/05/24. eng.
  27. Gao H, Yao H, Yang S, Li L. From SARS to MERS: evidence and speculation. Frontiers of medicine. 2016 Dec;10(4):377-82. PubMed PMID: 27726088. Epub 2016/10/12. eng.